These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 9731198

  • 1. Cellular responses in mouse leukemia L1210 cells made resistant to deoxyadenosine.
    Cory AH, Cory JG.
    Biochem Biophys Res Commun; 1998 Aug 28; 249(3):687-91. PubMed ID: 9731198
    [Abstract] [Full Text] [Related]

  • 2. Apoptosis induced by inhibitors of nucleotide synthesis in deoxyadenosine-resistant leukemia L1210 cells that lack p53 expression.
    Cory AH, Hickerson DH, Cory JG.
    Anticancer Res; 2000 Aug 28; 20(6B):4171-8. PubMed ID: 11205244
    [Abstract] [Full Text] [Related]

  • 3. Enhanced roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells.
    Somerville L, Cory JG.
    Anticancer Res; 2000 Aug 28; 20(5B):3347-55. PubMed ID: 11131634
    [Abstract] [Full Text] [Related]

  • 4. Augmentation of apoptosis responses in p53-deficient L1210 cells by compounds directed at blocking NFkappaB activation.
    Cory AH, Cory JG.
    Anticancer Res; 2001 Aug 28; 21(6A):3807-11. PubMed ID: 11911251
    [Abstract] [Full Text] [Related]

  • 5. Altered sensitivity of deoxyadenosine-resistant mouse leukemia L1210 cells to various kinase inhibitors.
    Somerville L, Cory JG.
    Anticancer Res; 1999 Aug 28; 19(2A):1021-6. PubMed ID: 10368649
    [Abstract] [Full Text] [Related]

  • 6. Altered steady-state levels of the messenger RNAs for c-myc and p53 in L1210 cell lines resistant to deoxyadenosine.
    Cory JG, Cory AH, Long SD, Carter GL, Johnson CE.
    Cancer Res; 1992 Apr 01; 52(7):2000-3. PubMed ID: 1551129
    [Abstract] [Full Text] [Related]

  • 7. Increased sensitivity to sodium salicylate-induced apoptosis in drug-resistant leukemia L1210 cells.
    Hall JG, Cory AH, Hickerson DH, Cory JG.
    Anticancer Res; 2001 Apr 01; 21(1A):173-80. PubMed ID: 11299731
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on wild type and variant mouse leukemia L1210 cells.
    Cory AH, Hertel LW, Kroin JS, Cory JG.
    Oncol Res; 1993 Apr 01; 5(2):59-63. PubMed ID: 8364254
    [Abstract] [Full Text] [Related]

  • 15. Selective resistance of L1210 cell lines to inhibitors directed at the subunits of ribonucleotide reductase.
    Carter GL, Cory JG.
    Adv Enzyme Regul; 1989 Apr 01; 29():123-39. PubMed ID: 2699151
    [Abstract] [Full Text] [Related]

  • 16. Bis(2-hydroxybenzylidene)acetone, a potent inducer of the phase 2 response, causes apoptosis in mouse leukemia cells through a p53-independent, caspase-mediated pathway.
    Dinkova-Kostova AT, Cory AH, Bozak RE, Hicks RJ, Cory JG.
    Cancer Lett; 2007 Jan 08; 245(1-2):341-9. PubMed ID: 16517063
    [Abstract] [Full Text] [Related]

  • 17. Kinetics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells.
    Moyer JD, Smith PA, Levy EJ, Handschumacher RE.
    Cancer Res; 1982 Nov 08; 42(11):4525-31. PubMed ID: 7127293
    [Abstract] [Full Text] [Related]

  • 18. Ribonucleotide reductase R2 gene expression and changes in drug sensitivity and genome stability.
    Huang A, Fan H, Taylor WR, Wright JA.
    Cancer Res; 1997 Nov 01; 57(21):4876-81. PubMed ID: 9354452
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
    Cory JG, Carter GL.
    Cancer Res; 1988 Feb 15; 48(4):839-43. PubMed ID: 3276399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.